Seres Therapeutics News

Seres Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow JonesNov 14 11:21 ET

Seres Therapeutics Price Target Maintained With a $10.00/Share by Canaccord Genuity

Dow JonesNov 14 11:21 ET

Promising Developments and Financial Stability Drive Buy Rating for Seres Therapeutics

TipRanksNov 14 07:30 ET

Seres Therapeutics Analyst Ratings

BenzingaNov 13 18:57 ET

Chardan Capital Maintains Buy on Seres Therapeutics, Maintains $1.25 Price Target

BenzingaNov 13 18:57 ET

TD Cowen Maintains Seres Therapeutics(MCRB.US) With Buy Rating

Moomoo NewsNov 13 11:32 ET

Seres Therapeutics (MCRB) Gets a Buy From TD Cowen

TipRanksNov 13 10:58 ET

Seres Therapeutics Analyst Ratings

BenzingaOct 24 07:09 ET

J.P. Morgan Downgrades Seres Therapeutics(MCRB.US) to Sell Rating

Moomoo NewsOct 23 18:31 ET

Seres Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow JonesSep 13 14:48 ET

Seres Therapeutics Price Target Maintained With a $10.00/Share by Canaccord Genuity

Dow JonesSep 13 14:48 ET

Seres Therapeutics Analyst Ratings

BenzingaSep 13 14:38 ET

Oppenheimer Maintains Seres Therapeutics(MCRB.US) With Hold Rating

Moomoo NewsSep 13 08:31 ET

CCORF Maintains Seres Therapeutics(MCRB.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsSep 13 07:31 ET

Analysts Offer Insights on Healthcare Companies: Seres Therapeutics (MCRB), BioMarin Pharmaceutical (BMRN) and Exact Sciences (EXAS)

TipRanksSep 13 07:10 ET

Buy Rating Affirmed for Seres Therapeutics Amid Strong Clinical Outcomes for SER-155

TipRanksSep 13 07:09 ET

Chardan Capital Maintains Seres Therapeutics(MCRB.US) With Buy Rating, Maintains Target Price $1.25

Moomoo NewsSep 12 22:31 ET

Buy Rating Affirmed for Seres Therapeutics' SER-155 Amid Anticipated Positive Impact on Infection and GvHD Rates

TipRanksAug 22 06:58 ET

TD Cowen Maintains Seres Therapeutics(MCRB.US) With Buy Rating

Moomoo NewsAug 15 06:37 ET

Oppenheimer Maintains Seres Therapeutics(MCRB.US) With Hold Rating

Moomoo NewsAug 15 02:32 ET